Breakthrough T1D Funded Clinical Trial Testing Islet Cell Transplantation with Eledon's Tegoprubart Expands to Include People with Type 1 Diabetes and Kidney Disease
October 21, 2026
October 21, 2026
NEW YORK, Oct. 21 -- Breakthrough T1D (formerly JDRF) a non-profit dedicated to funding type 1 diabetes research, posted the following news release:
* * *
Breakthrough T1D Funded Clinical Trial Testing Islet Cell Transplantation with Eledon's Tegoprubart Expands to Include People with Type 1 Diabetes and Kidney Disease
*
NEW YORK, Oct. 21, 2026--A new clinical trial funded by Breakthrough T1D recently launched and is testing islet cell tra . . .
* * *
Breakthrough T1D Funded Clinical Trial Testing Islet Cell Transplantation with Eledon's Tegoprubart Expands to Include People with Type 1 Diabetes and Kidney Disease
*
NEW YORK, Oct. 21, 2026--A new clinical trial funded by Breakthrough T1D recently launched and is testing islet cell tra . . .